Stocks · News reference
Sun Pharma Receives US FDA Approval for ILUMYA in Psoriatic Arthritis
Sun Pharmaceutical Industries Limited has secured US FDA approval for its drug ILUMYA to treat psoriatic arthritis.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
No Linked Headlines Yet
The feed will populate when a captured headline is linked to this market.